Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial.

Jun GuoJie JinMototsugu OyaHirotsugu UemuraShunji TakahashiKatsunori TatsugamiSun Young RhaJae-Lyun LeeJinsoo ChungHo Yeong LimHsi Chin WuYen Hwa ChangArun AzadIan D DavisMarlene J Carrasco-AlfonsoBhupinder NanuaJackie HanQasim AhmadRobert J Motzer

Published in: Journal of hematology & oncology (2018)

ClinicalTrials.gov, NCT00720941 , Registered July 22, 2008 ClinicalTrials.gov, NCT01147822 , Registered June 22, 2010.

Keyphrases

metastatic renal cell carcinoma
phase iii
clinical trial
study protocol
hiv infected
phase ii
open label
combination therapy
renal cell carcinoma